Pulmonology

SalivaDirect eliminates the need for nucleic acid extraction kits, enhancing the potential capacity for testing.

Dr. Louis Kovacs discusses the risk of playing youth, college, and professional sports during the ongoing pandemic.

From immunity building to plasma research, a look at some lesser efficient practices adopted or proposed during the pandemic.

Patients with IPF and multiple comorbidities experienced similar effects from nintedanib to those with few or no comorbidities.

Tiotropium plus olodaterol is more effective for patients with COPD compared with LABA plus inhaled corticosteroids.

Results of ANDHI provide additional support on the safety and efficacy of benralizumab for patients with asthma.

Dupilumab significantly reduces exacerbation rates in patients with asthma compared to standard of care.

In a study presented virtually at ATS 2020, investigators find 15 mg of the study drug resulted in a 43% decrease in FeNO.

A new case study  assesses biopsy and autopsy tissues to characterize pathological patterns in suspected EVALI cases .

In a study presented at ATS 2020, investigators test 3 different dosing regimens of tezepelumab in asthma patients with both high and low levels of IL-5 and IL-13.

A famed virologist weighs in on the country's earliest shortcomings—and how they can still be resolved today.

A one-time intramuscular dose of the investigative drug was linked to reduced medical attention and hospitalizations related to RSV.

New findings suggest differing chronic lung diseases are associated with varying risk factors among COVID-19 patients.

World-leading virologist and AIDS researcher David Ho, MD, joins the inaugural podcast episode.

A discussion on how thromboembolism research and care could benefit from progression in diagnostics.

Patients with a mPAP of at least 19 mm Hg and pulmonary artery wedge pressure of 15 mm Hg or less had an adjusted hazard ratio for mortality of 1.71.

The approval are based on a pair of recent phase 3 trials showing the safety and efficacy of budesonide/glycopyrrolate/formoterol fumarate.

Until more is known about long-term cardiac mechanisms behind MIS-C, providers could consider following Kawasaki disease guidelines for follow-up care

A two-week period of downward COVID-19 cases is needed before reigniting elective procedures.

Genomics, in combination with patient demographic risks, could help better inform clinicians of persons at risk for worsened chronic pulmonary burden.

A noninferiority study showed parents were not more anxious when their discharged child was treated as-need—nor was their child at greater health risk.

There is also an association between late onset of spring and an increase in hospital admissions for asthma.

ADHD, autism spectrum disorder, seizures, and even developmental delays are asssociated with a two-fold risk of asthma in US children.

Dexamethasone should also be used for up to 10 days in patients with COVID-19 who require supplemental oxygen but are not mechanically ventilated.

Where do investigators go next with the 8000-plus COPD patient research?